Vincent Weynants
10Patents
3h-index
19Co-inventors
53Inventor score
Filing activity: Jul 31, 2003 → Aug 13, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7838014B2 | Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB- Neisseria meningitidis | Emerging Cross-Sectional Technologies | 14 | Active |
| US8221770B2 | Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis | Emerging Cross-Sectional Technologies | 7 | Active |
| US8679770B2 | Serum bactericidal assay for N. meningitidis specific antisera | Physics | 6 | Active |
| US9259461B2 | Vaccine comprising protein NMB0964 from Neisseria meningitidis | Human Necessities | 2 | Active |
| US9365624B2 | Vaccine | Emerging Cross-Sectional Technologies | 2 | Active |
| US7955817B2 | Vaccine protection assay | Emerging Cross-Sectional Technologies | 0 | Active |
| US11167022B2 | Immunogenic composition, use and method of treatment | Human Necessities | 0 | Active |
| US9023606B2 | Vaccine protection assay | Emerging Cross-Sectional Technologies | 0 | Active |
| US11723966B2 | Methods of boosting immune responses | Human Necessities | 0 | Active |
| US9567377B2 | Immunogenic composition | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.